Skip to main content

Basel is artificial intelligence hub

| News

Basel is artificial intelligence hub

03.09.2019

The canton of Basel-Stadt is one of the three largest Swiss technology clusters for advanced digitalization technologies, as the new Digitalization Atlas has revealed. It is especially strong in artificial intelligence, with Roche, in particular, filing many patents in this area.

Digitalization Atlas of Switzerland for the technology Artificial Intelligence (Image: EconSight)

The economic research and consulting company EconSight has published its latest Digitalization Atlas. In this, it examines the patent activities of companies in advanced digitalization technologies across the various regions of Switzerland, with the aim of highlighting where local technology clusters can be found.

According to the results, the canton of Basel-Stadt is one of the three largest clusters for advanced digitalization technologies in Switzerland. With these technologies, EconSight means artificial intelligence, encryption, big data, cloud computing and virtual reality. In total, companies and research facilities in the canton of Basel-Stadt have filed 202 patents in these areas.

According to the Digitalization Atlas, the technological focus of Basel-Stadt is artificial intelligence, with 75 percent of advanced digitalization patents within this field. This trend is above all driven by the Basel-based pharma giant Roche. In Switzerland, Roche holds the highest number of patents in artificial intelligence (115 patents). Roche is followed by Zurich technology company ABB (108 patents) and, by quite some margin, Google’s parent company Alphabet (40 patents).

Roche remains the clear leader even when all five technology categories are taken into account. With 149 patents, the Group ranks third behind the Western Swiss company Kudelski (213 patents) and ABB (196 patents).

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.